InvestorsHub Logo
Followers 72
Posts 6896
Boards Moderated 0
Alias Born 12/07/2011

Re: A deleted message

Thursday, 03/15/2018 8:24:01 PM

Thursday, March 15, 2018 8:24:01 PM

Post# of 403039
Do me a favor BOARD! B4 u read further and expand - imagine your on SHARK TANK: Now reread what this company is trying to accomplish in an untapped multi billion indication;


Summary Points

Brilacidin-OM viewed by Company to have significant competitive advantages and less challenges than other OM drug candidates:
Prevention: Effective reduction of SOM incidence, beyond providing symptom relief, would be a critical factor toward successful commercialization
Delivery: Brilacidin-OM developed in sachet packets offers a portable, quick-mixing, “instant” oral rinse therapy—patients and providers likely would more readily adopt
Cost: Brilacidin-OM avoids costly manufacturing and logistics of sterile IV therapy competitors amid a regulatory environment demanding lower drug prices
Company preparing for U.S. Food and Drug Administration (FDA) meeting to discuss Brilacidin-OM development plan
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News